>아시아 태평양 지역의 생물정보학 AI 시장, 제공 분야(소프트웨어, 서비스 등), 유형(머신러닝, 딥러닝 등), 제품 및 서비스(지식 관리 도구, 생물정보학 플랫폼 및 생물정보학 서비스), 응용 분야(유전체학, 마이크로어레이, 시스템 생물학, 텍스트 마이닝, 화학정보학 및 약물 설계, 단백체학, 전사체학, DNA 시퀀싱, 대사체학 등), 부문(의료 생명공학, 동물 생명공학, 식물 생명공학, 환경 생명공학, 법의학 생명공학 등) - 산업 동향 및 2029년까지의 예측.
아시아 태평양 AI 생물정보학 시장 분석 및 규모
유전자 시퀀싱 비용의 감소는 시장 수요를 증가시켰습니다. 더 나은 건강 서비스를 위한 의료비 지출 증가도 시장 성장에 기인합니다. 주요 시장 참여자들은 이 중요한 기간 동안 다양한 서비스 출시와 서비스 승인에 매우 집중하고 있습니다. 또한, 생물정보학에 대한 수요 증가와 생물정보학에 대한 공공-민간 부문 자금 지원 증가도 시장 수요 증가에 기여하고 있습니다.
아시아 태평양 AI in bioinformatics 시장은 시장 참여자의 증가와 고급 서비스의 가용성으로 인해 예측 연도에 성장하고 있습니다. 이와 함께 제조업체는 시장에서 새로운 서비스를 출시하기 위한 R&D 활동에 참여하고 있습니다. 생물정보학 기술의 발전이 시장 성장을 더욱 촉진하고 있습니다. 그러나 생물정보학의 계측기 비용과 사이버 보안 문제가 예측 기간 동안 아시아 태평양 AI in bioinformatics 시장의 성장을 방해할 수 있습니다.
Data Bridge Market Research는 생물정보학 분야의 AI 시장이 2029년까지 4,740.88백만 달러에 도달할 것으로 예상하며, 예측 기간 동안 CAGR은 37.7%라고 분석했습니다. "서비스"는 생물정보학 분야에서 핸드헬드 AI 사용을 상용화하기 위한 기술 경로의 빠른 발전으로 인해 생물정보학 분야의 AI 시장에서 가장 큰 기술 부문을 차지합니다. 생물정보학 분야의 AI 시장 보고서는 또한 가격 분석, 특허 분석 및 심층적인 기술 발전을 다룹니다.
보고서 메트릭 |
세부 |
예측 기간 |
2022년부터 2029년까지 |
기준 연도 |
2021 |
역사적 해 |
2020 (2019-2014로 사용자 정의 가능) |
양적 단위 |
수익은 백만 달러, 가격은 미화로 표시됨 |
다루는 세그먼트 |
제공(소프트웨어, 서비스 및 기타), 유형(머신러닝, 딥러닝 및 기타), 제품 및 서비스(지식 관리 도구, 생물정보학 플랫폼 및 생물정보학 서비스), 응용 프로그램(유전체학, 마이크로어레이, 시스템 생물학, 텍스트 마이닝, 화학정보학 및 약물 설계, 프로테오믹스, 전사체학, DNA 시퀀싱, 대사체학 및 기타), 부문(의료 생명공학, 동물 생명공학, 식물 생명공학, 환경 생명공학, 법의학 생명공학 및 기타) |
적용 국가 |
China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific in Asia-Pacific |
Market Players Covered |
SOPHiA GENETICS, Biomax Informatics Inc., QIAGEN, NeoGenomics Laboratories, Eurofins Scientific, Illumina, Inc., Thermo Fisher Scientific Inc., Strand Life Sciences, Dassault Systmes, SomaLogic Operating Co., Inc., Elucidata and among others. |
Market Definition
Bioinformatics is a sub-discipline that has to do with the analysis of sequences of biological molecules. It usually refers to genes, DNA, RNA, or protein and is particularly useful in comparing genes, and other sequences in proteins and different sequences within an organism or between organisms, looking at the evolutionary relationships between organisms and using the patterns that exist across DNA and protein sequences to figure out what their function is.
Bioinformatics combines computer programming, big data, and molecular biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.
From genetics to toxicology to mycology and radiobiology, there are scores of branches of biology to specialize in. And out of the many, bioinformatics is one of the intriguing fields which enables you to identify, evaluate, store, and retrieve biological information. Being an interdisciplinary field of study, it incorporates various applications of computer science, statistics, and biology to develop software applications for understanding biological data like DNA sequencing, protein analysis, evolutionary genetics, and others.
In the coming future, important decisions related to bioinformatics on drug discovery will be made by individuals who not only understand biology but can also use the bioinformatics tools and the knowledge they release to develop hypotheses and identify the quality target.
AI in Bioinformatics Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:
- Growing demand for bioinformatics
As genomics focused pharmacology continues to play a greater role in the treatment of various chronic diseases, especially cancer, next-generation sequencing (NGS) is evolving as a powerful tool for providing a deeper and more precise insight at the molecular underpinnings of individual tumors and specific receptors. Informatics is essential in biological research, which involves biologists who learn programming, computer programmers, mathematicians, or database managers to learn the foundations of biology.
- Reduction in the genetic sequencing cost
The strong demand for decreasing the cost of genomics and biomarker prediction has contributed to the creation of high-throughput genome sequencing, which often goes by the name next-generation sequencing (NGS). Thousands or millions of sequences in a single bioinformatics cycle are generated simultaneously. Dramatic upgrades to industrial NGS technologies have culminated in dramatic cutbacks in DNA sequencing cost-per-base. Thus recently, the main sequencing techniques have become the key subject of research, with sample design optimization taking a secondary function.
- Increasing public-private sector funding for bioinformatics
In order to improve the workflow for bioinformatics, the federal agencies, the public, and the private agencies are providing funds in order to carry out bioinformatics projects and to scientists for research purposes. It is important to approach possible funders with a clear proposal and strategy of what is to be achieved in terms of bioinformatics capacity building in the institution as well as the intended outputs and outcomes. Many government bodies and private organizations across the globe are increasingly investing in the field of bioinformatics. These investments have largely resulted in data and technological advancements in bioinformatics services, which in return, have improved the quality of these services.
- High cost of instrumentation
The cost of the device plays a major factor in the market. The AI based bioinformatics instrument is highly sophisticated, need high validation, and other specification increase. Genomics instruments are also equipped with advanced features and functionalities and are priced at a premium, ranging between USD 10–20 million. As pharmaceutical companies and research laboratories require many such systems, their capital expenditure on procuring multiple genomic instruments is very high. In the case of small and medium-sized pharmaceutical companies and research laboratories, it is not feasible for them to make such high investments in multiple genomics instruments. Hence, the high cost of AI based equipment is expected to restrain the market growth.
- Strategic initiatives of key players
The dramatic rise in the quality of research coupled with increasing research opportunities is because of various strategic initiatives taken by key market players. They are taking initiatives such as product launches, collaborations, mergers, acquisitions, and many more over the years and are expected to lead and create more opportunities in the market.
By successfully working with new technology firms to ensure continued growth, creativity, and viability in the industry, healthcare product suppliers have a huge opportunity. Health enterprises that implement technology-enabled technologies will explore new modes of goods for patient care, streamline processes, and engage patients more.
To discover and develop advanced bioinformatics products, companies are launching new initiatives, and collaborating with other key players to deliver more reliable results and services.
- Advancement in bioinformatics technology
The dimensions and cost of bioinformatics platforms and instruments are decreasing, allowing easier uptake by public health laboratories. Although currently, AI based bioinformatics requires highly specialized equipment and substantially skilled staff to analyze the data, it is unlikely that the bioinformatics revolution has finished. With rising technology upgradation of instruments and techniques is also needed, moreover, the bioinformatics market has a vast potential to upgrade in various applications, and there are high chances of the advancement of bioinformatics techniques in the forecasted period.
- Lack of skilled professionals to perform AI based bioinformatics technology
One of biology's most rapidly developing fields of study is bioinformatics, which involves the development and use of computational tools for the collection, archiving, organisation, analysis, and visualisation of biological data. The advancement of technology has made it possible to reach the level of next-generation analysis from conventional data analysis methods. The advancement of the technology of bioinformatics requires various skill sets for its handling. As the bioinformatics platforms are highly automated and costly machines, the improper handling of such machines can damage their parts which can hamper achieving analysis and visualisation of biological data. Thereby, it will proportionally hamper the result of data processing. The dearth of skilled professionals having adequate skills and knowledge to perform next-generation sequencing, therefore, hampers the growth of the market.
Post COVID-19 Impact on AI in Bioinformatics Market
During the pandemic, the bioinformatics sector is one that focused on using the combination of biology and information technology. At the heart of the industry is biological data, which is analyzed and transformed using IT techniques. Bioinformatics has always had huge potential when it comes to providing essential support to many areas of scientific research. The tools that bioinformatics can provide allow scientists to get to grips with larger data sets to mine and analyses them to discover crucial information that could lead to key discoveries. genetics and genomes have been the primary focus of bioinformatics in recent years, including comparative genomics, DNA microarrays, and functional genomics.
The growth of the AI in bioinformatics market is increasing with the growing demand for analysis tools in drug discovery and development and the integration of AI in various fields to interpret the data more conveniently. Hence, the market is expected to grow significantly in the forecast period, whereas the cost and the complexity of AI integration may hamper the market growth. The intervention of COVID-19 has increased the R&D activities, which in turn positively add to the market growth.
Recent Developments
- In June 2022, SOPHiA GENETICS, a leader in data-driven medicine, announced from the ESHG Conference in Vienna that it has achieved CE-IVD certification for the analytical functionality supported by its cloud-based SOPHiA DDM™ Platform, an accessory to diagnostic applications. With this certification, the SOPHiA DDM™ Platform is now IVD-ready to support all applications and modules designed for diagnostic purposes in the European Union and other markets recognizing this certification. This has helped the company to increase its Asia-Pacific presence in the market.
- In December 2021, JADBio and BioLizard announced their partnership. BioLizard is agile bioinformatics and AI/ML company Asia-Pacifically servicing clients in the life sciences, biotechnology, and pharmaceutical industries. JADBio is a robust automated machine learning platform that allows intuitive, timely, and interactive creation of ML predictive models on BioMedical and Multi-omics data while allowing for knowledge (biomarker signature) discovery through its vast range of reporting and analysis. This has helped the company to expand its products and services portfolio in the market.
Asia-Pacific AI in bioinformatics Market Scope
Asia-Pacific AI in bioinformatics market is segmented on the basis of offering, type, products and services, application, and sector. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Offering
- Services
- Software
- Others
On the basis of offering, the Asia-Pacific AI in bioinformatics market is segmented into services, software, and others.
Type
- Machine Learning
- Deep Learning
- Others
On the basis of type, the Asia-Pacific AI in bioinformatics market has been segmented into machine learning, deep learning, and others.
Products and Services
- Bioinformatics Services
- Bioinformatics Platforms
- Knowledge Management Tools
On the basis of products and services, the Asia-Pacific AI in bioinformatics market has been segmented into bioinformatics services, bioinformatics platforms, and knowledge management tools.
Application
- Genomics
- Chemoinformatics & Drug Design
- Proteomics
- DNA Sequencing
- System Biology
- Transcriptomics
- Text Mining
- Microarrays
- Metabolomics
- Others
On the basis of application, the Asia-Pacific AI in bioinformatics market has been segmented into below genomics, chemoinformatics & drug design, proteomics, DNA sequencing, system biology, transcriptomics, text mining, microarrays, metabolomics and others.
Sector
- Medical Biotechnology
- Animal Biotechnology
- Plant Biotechnology
- Environmental Biotechnology
- Forensic Biotechnology
- Others
On the basis of sector, the Asia-Pacific AI in bioinformatics market has been segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and others.
AI in Bioinformatics Market Regional Analysis/Insights
The AI in bioinformatics market is analysed, and market size insights and trends are provided by country, offering, type, products and services, application, and the sector as referenced above.
The countries covered in the Asia-Pacific AI in bioinformatics market report are China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific. China is expected to dominate the Asia-Pacific AI in bioinformatics market due to the rising demand for advanced technology in bioinformatics for drug discovery, and genomics, among others. However, the complexity of understanding AI and its development is expected to hinder the market growth in the forecast period.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
China is expected to dominate the Asia-pacific AI in bioinformatics market due to the rise in technological advancement in the AI and the rise in integration of AI in various fields. China is followed by Japan due to the rise in technological advancements in the country, and South Korea is attributed to the fact of rising in drug discovery and development demands and rise in clinical trials.
Competitive Landscape and AI in bioinformatics Market Share Analysis
생물정보학 시장 경쟁 구도의 AI는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 아시아 태평양 지역 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우세입니다. 위에 제공된 데이터 포인트는 회사가 생물정보학 시장에서 AI에 집중하는 것과만 관련이 있습니다.
생물정보학 분야의 AI 시장에서 활동하는 주요 기업으로는 SOPHiA GENETICS, Biomax Informatics Inc., QIAGEN, NeoGenomics Laboratories, Eurofins Scientific, Illumina, Inc., Thermo Fisher Scientific, Inc., Strand Life Sciences, Dassault Systèmes, SomaLogic Operating Co., Inc., Elucidata 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC AI IN BIOINFORMATICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 OFFERING LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET SECTOR COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 REDUCTION IN THE GENETIC SEQUENCING COST
5.1.2 GROWING DEMAND FOR BIOINFORMATICS
5.1.3 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS
5.2 RESTRAINTS
5.2.1 HIGH COST OF INSTRUMENTATION
5.2.2 CYBERSECURITY CONCERNS IN BIOINFORMATICS
5.3 OPPORTUNITIES
5.3.1 RISE IN HEALTHCARE EXPENDITURE
5.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS
5.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY
5.4 CHALLENGES
5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM AI-BASED BIOINFORMATICS TECHNOLOGY
5.4.2 CHALLENGES OF IMPLEMENTING BIOINFORMATIC TECHNOLOGY IN THE CLINICAL LAB
6 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY OFFERING
6.1 OVERVIEW
6.2 SERVICES
6.3 SOFTWARE
6.4 OTHERS
7 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY TYPE
7.1 OVERVIEW
7.2 MACHINE LEARNING
7.3 DEEP LEARNING
7.4 OTHERS
8 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES
8.1 OVERVIEW
8.2 BIOINFORMATICS SERVICES
8.2.1 DATA ANALYSIS
8.2.2 SEQUENCING SERVICES
8.2.3 DATABASE MANAGEMENT
8.2.4 OTHERS
8.3 BIOINFORMATICS PLATFORMS
8.3.1 SEQUENCE ANALYSIS PLATFORMS
8.3.2 SEQUENCE ALIGNMENT PLATFORMS
8.3.3 STRUCTURAL ANALYSIS PLATFORMS
8.3.4 SEQUENCE MANIPULATION PLATFORMS
8.3.5 OTHERS
8.4 KNOWLEDGE MANAGEMENT TOOLS
8.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS
8.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS
9 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 GENOMICS
9.3 CHEMOINFORMATICS & DRUG DESIGN
9.4 PROTEOMICS
9.5 DNA SEQUENCING
9.6 SYSTEM BIOLOGY
9.7 TRANSCRIPTOMICS
9.8 TEXT MINING
9.9 MICROARRAYS
9.1 METABOLOMICS
9.11 OTHERS
10 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY SECTOR
10.1 OVERVIEW
10.2 MEDICAL BIOTECHNOLOGY
10.3 ANIMAL BIOTECHNOLOGY
10.4 PLANT BIOTECHNOLOGY
10.5 ENVIRONMENTAL BIOTECHNOLOGY
10.6 FORENSIC BIOTECHNOLOGY
10.7 OTHERS
11 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY REGION
11.1 ASIA-PACIFIC
11.1.1 CHINA
11.1.2 JAPAN
11.1.3 SOUTH KOREA
11.1.4 INDIA
11.1.5 AUSTRALIA
11.1.6 SINGAPORE
11.1.7 THAILAND
11.1.8 MALAYSIA
11.1.9 INDONESIA
11.1.10 PHILIPPINES
11.1.11 REST OF ASIA-PACIFIC
12 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
13 SWOT ANALYSIS
14 COMPANY PROFILES
14.1 ILLUMINA, INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 DASSAULT SYSTEMES
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENT
14.3 EUROFINS SCIENTIFIC
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 THERMO FISHER SCIENTIFIC INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 QIAGEN
14.5.1 COMPANY SNAPSHOT
14.5.2 COMPANY SHARE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENTS
14.6 SOPHIA GENETICS
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 ARDIGEN
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 BIOMAX INFORMATICS AG
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENT
14.9 CELBRIDGESCIENCE.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 DNASTAR
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 ELUCIDATA
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 FIOS GENOMICS
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 INDX. AI.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENTS
14.14 INSILICO MEDICINE
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENTS
14.15 JADBIO & GNOSIS DATA ANALYSIS
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.16 NEOGENOMICS LABORATORIES
14.16.1 COMPANY SNAPSHOT
14.16.2 REVENUE ANALYSIS
14.16.3 PRODUCT PORTFOLIO
14.16.4 RECENT DEVELOPMENTS
14.17 PAIGE AI, INC.
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENTS
14.18 SOMALOGIC OPERATING CO., INC.
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENTS
14.19 SOURCE BIOSCIENCE.
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 STRAND LIFE SCIENCES
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
표 목록
TABLE 1 BIOINFORMATICS COST PER SAMPLE
TABLE 2 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 3 ASIA PACIFIC SERVICES IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 ASIA PACIFIC SOFTWARE IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC OTHERS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 7 ASIA PACIFIC MACHINE LEARNING IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 ASIA PACIFIC DEEP LEARNING IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC OTHERS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 11 ASIA PACIFIC BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 ASIA PACIFIC BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 15 ASIA PACIFIC KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 ASIA PACIFIC KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 18 ASIA PACIFIC GENOMICS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 ASIA PACIFIC CHEMOINFORMATICS & DRUG DESIGN IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC PROTEOMICS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC DNA SEQUENCING IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC SYSTEM BIOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC TRANSCRIPTOMICS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 ASIA PACIFIC TEXT MINING IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 ASIA PACIFIC MICROARRAYS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 ASIA PACIFIC METABOLOMICS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 ASIA PACIFIC OTHERS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 29 ASIA PACIFIC MEDICAL BIOTECHNOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 ASIA PACIFIC ANIMAL BIOTECHNOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 ASIA PACIFIC PLANT BIOTECHNOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 32 ASIA PACIFIC ENVIRONMENTAL BIOTECHNOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 ASIA PACIFIC FORENSIC BIOTECHNOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 ASIA PACIFIC OTHERS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 ASIA-PACIFIC AI IN BIOINFORMATICS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 36 ASIA-PACIFIC AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 37 ASIA-PACIFIC AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 38 ASIA-PACIFIC AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 39 ASIA-PACIFIC BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 40 ASIA-PACIFIC BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 41 ASIA-PACIFIC KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 42 ASIA-PACIFIC AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 43 ASIA-PACIFIC AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 44 CHINA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 45 CHINA AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 46 CHINA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 47 CHINA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 48 CHINA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 49 CHINA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 50 CHINA AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 51 CHINA AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 52 JAPAN AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 53 JAPAN AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 54 JAPAN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 55 JAPAN BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 56 JAPAN BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 57 JAPAN KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 58 JAPAN AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 59 JAPAN AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 60 SOUTH KOREA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 61 SOUTH KOREA AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 62 SOUTH KOREA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 63 SOUTH KOREA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 64 SOUTH KOREA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 65 SOUTH KOREA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 66 SOUTH KOREA AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 67 SOUTH KOREA AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 68 INDIA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 69 INDIA AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 70 INDIA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 71 INDIA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 72 INDIA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 73 INDIA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 74 INDIA AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 75 INDIA AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 76 AUSTRALIA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 77 AUSTRALIA AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 78 AUSTRALIA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 79 AUSTRALIA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 80 AUSTRALIA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 81 AUSTRALIA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 82 AUSTRALIA AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 83 AUSTRALIA AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 84 SINGAPORE AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 85 SINGAPORE AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 86 SINGAPORE AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 87 SINGAPORE BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 88 SINGAPORE BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 89 SINGAPORE KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 90 SINGAPORE AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 91 SINGAPORE AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 92 THAILAND AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 93 THAILAND AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 94 THAILAND AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 95 THAILAND BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 96 THAILAND BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 97 THAILAND KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 98 THAILAND AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 99 THAILAND AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 100 MALAYSIA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 101 MALAYSIA AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 102 MALAYSIA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 103 MALAYSIA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 104 MALAYSIA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 105 MALAYSIA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 106 MALAYSIA AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 107 MALAYSIA AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 108 INDONESIA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 109 INDONESIA AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 110 INDONESIA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 111 INDONESIA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 112 INDONESIA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 113 INDONESIA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 114 INDONESIA AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 115 INDONESIA AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 116 PHILIPPINES AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 117 PHILIPPINES AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 118 PHILIPPINES AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 119 PHILIPPINES BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 120 PHILIPPINES BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 121 PHILIPPINES KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 122 PHILIPPINES AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 123 PHILIPPINES AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 124 REST OF ASIA-PACIFIC AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
그림 목록
FIGURE 1 ASIA PACIFIC AI IN BIOINFORMATICSMARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: MARKET SECTOR COVERAGE GRID
FIGURE 9 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: SEGMENTATION
FIGURE 11 THE REDUCTION IN THE GENETIC SEQUENCING COST AND GROWING DEMAND FOR BIOINFORMATICS ARE EXPECTED TO DRIVE THE ASIA PACIFIC AI IN BIOINFORMATICS MARKET IN THE FORECAST PERIOD
FIGURE 12 SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC AI IN BIOINFORMATICS MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA PACIFIC AI IN BIOINFORMATICS MARKET
FIGURE 14 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY OFFERING, 2021
FIGURE 15 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY OFFERING, 2022-2029 (USD MILLION)
FIGURE 16 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY OFFERING, CAGR (2022-2029)
FIGURE 17 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY OFFERING, LIFELINE CURVE
FIGURE 18 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY TYPE, 2021
FIGURE 19 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY TYPE, 2022-2029 (USD MILLION)
FIGURE 20 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 21 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, 2021
FIGURE 23 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, 2022-2029 (USD MILLION)
FIGURE 24 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, CAGR (2022-2029)
FIGURE 25 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, LIFELINE CURVE
FIGURE 26 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY APPLICATION, 2021
FIGURE 27 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 28 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 29 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 30 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY SECTOR, 2021
FIGURE 31 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY SECTOR, 2022-2029 (USD MILLION)
FIGURE 32 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY SECTOR, CAGR (2022-2029)
FIGURE 33 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: BY SECTOR, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC AI IN BIOINFORMATICS MARKET: SNAPSHOT (2021)
FIGURE 35 ASIA-PACIFIC AI IN BIOINFORMATICS MARKET: BY COUNTRY (2021)
FIGURE 36 ASIA-PACIFIC AI IN BIOINFORMATICS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 37 ASIA-PACIFIC AI IN BIOINFORMATICS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 38 ASIA-PACIFIC AI IN BIOINFORMATICS MARKET: BY OFFERING (2022-2029)
FIGURE 39 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: COMPANY SHARE 2021 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.